Skip to main content
Clinical Trials/NCT01902108
NCT01902108
Completed
Phase 4

Randomized Double-blind Trial Comparing the Post-operative Analgesic Efficacy of Local Wound Infiltration With Bupivacaine Alone to Bupivacaine With Clonidine in Posterior Spine Surgeries

St Joseph University, Beirut, Lebanon1 site in 1 country225 target enrollmentJanuary 2013

Overview

Phase
Phase 4
Intervention
Clonidine
Conditions
Post-operative Pain
Sponsor
St Joseph University, Beirut, Lebanon
Enrollment
225
Locations
1
Primary Endpoint
Mean Area under curve
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The objective of this prospective randomized double-blind study is to evaluate the added analgesic value of clonidine to the conventional local bupivacaine wound infiltration in posterior spine surgery.

Detailed Description

Patients candidates to posterior spine surgery (Micro-discectomy, Lumbar laminectomy with or without fusion, cervical laminectomy) are asked to participate to this prospective study. After verification of inclusion and exclusion criteria, patients consenting to enter the study are randomly assigned to one of the following subgroups: 1-Pre-incisional wound infiltration with 20 mL of bupivacaine 0.25%. 2- Pre-incisional wound infiltration with 150 μg of clonidine with 20 mL of bupivacaine 0.25%. Demographic parameters, co-morbidities and other pre and per operative medical data are noted. In the post-operative period, patients received a standardized post-operative analgesic protocol (NSAI and paracetamol). Patients are asked to fill their pain diary using Visual Analog Scale (VAS) from day 0 till day 8 after surgery. Morphine rescue consumption is noted. Finally, the percentage of global subjective patient satisfaction regarding the post-operative wound pain is noted from 0 to 100.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
December 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
St Joseph University, Beirut, Lebanon
Responsible Party
Principal Investigator
Principal Investigator

Dr Joseph Maarrawi

Assistant Professor : Researcher - Pain Specialist - Neurosurgeon

St Joseph University, Beirut, Lebanon

Eligibility Criteria

Inclusion Criteria

  • First (not recurrent) posterior spinal surgery at the operated site
  • American Society of Anesthesiologists class I or II (operative risk)

Exclusion Criteria

  • Allergy to local anesthetics or to clonidine
  • Pregnancy
  • Raynaud's syndrome
  • Thromboangiitis obliterans
  • History of substance abuse
  • Current treatment with corticosteroids

Arms & Interventions

Clonidine

Clonidine 150μg added to bupivacaine in a local infiltration before wound incision

Intervention: Clonidine

Bupivacaine

Bupivacaine 0.25 % alone in the wound infiltration

Intervention: Bupivacaine

Outcomes

Primary Outcomes

Mean Area under curve

Time Frame: From the day of surgery till the 8th postoperative day (9 days and 8 nights=200h

Pain is assessed on numeric rating scale (NRS) 8times/day during the first 3 days, 3times/day during the next 6days and one mean value during the night. The mean intensity of daily pain is obtained from the different values mentioned during day and night corrected by the duration covered by every value. It may vary from 0 to 10.

Secondary Outcomes

  • Area under Curve (AUC) of pain(Calculated at Day 0-2, Day3-5, Day6-8 and all along the follow-up from Day0 till Day8)
  • Daily rescue opiates consumption(From the day of surgery till the 3rd postoperative day)
  • Global subjective patient satisfaction of post-operative wound pain control(Assessed at the end of follow-up on Day 8)

Study Sites (1)

Loading locations...

Similar Trials